Basilea Pharmaceutica(BPMUF)
$85.13+1.13 (+1.34%)
BPMUF
Basilea Pharmaceutica earnings date
$85.13
At close:+1.13 (+1.34%)
Basilea Pharmaceutica (BPMUF) Q2 2018 Earnings Report
0 Followers
BPMUF Q2 2018 EPS Results
- Actual EPS
- -$2.53
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$2.32
BPMUF Q2 2018 Revenue Results
- Actual Revenue
- $73.05M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 08/14/2018
- Time
- TBA
- Conference Call
- Tuesday, August 14, 2018
BPMUF Upcoming Earnings
Basilea Pharmaceutica's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
BPMUF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 5.13- | 2.43 | ― | ― |
| Aug 18, 2026 | 2026 (Q2) | 4.082.60 | 1.54 | 69.05% (+1.06) | |
| Feb 17, 2026 | 2025 (Q4) | 2.002.43 | 5.73 | -57.70% (-3.31) | |
| Aug 19, 2025 | 2025 (Q2) | 2.481.54 | 1.92 | -20.00% (-0.38) | |
| Feb 18, 2025 | 2024 (Q4) | 3.955.73 | -2.08 | 375.66% (+7.81) | |
| Aug 13, 2024 | 2024 (Q2) | 1.431.92 | 2.97 | -35.21% (-1.04) | |
| Feb 13, 2024 | 2023 (Q4) | -2.46-2.08 | 2.5 | -183.17% (-4.58) | |
| Aug 15, 2023 | 2023 (Q2) | 0.982.97 | -1.26 | 336.02% (+4.22) | |
| Feb 14, 2023 | 2022 (Q4) | -1.592.50 | 1.54 | 62.70% (+0.96) | |
| Aug 16, 2022 | 2022 (Q2) | -1.55-1.26 | -2.24 | 44.02% (+0.99) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
